Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Labetalol vs Nitroglycerin vs Nifedipine in Severe Pre-eclampsia
NCT06265415Not yet recruiting
- Sponsor
- Sohag University
- Start
- Mar 2024
- Primary completion
- Mar 2025
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of labetalol, nitroglycerin and nifedipine GITS in severe preeclampsia (3 arms), sponsored by Sohag University. Primary endpoint: Duration of control blood pressure at 1 year. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
labetalolnitroglycerinnifedipine GITS
03
Conditions
severe preeclampsia
Beyond the preview
Go deeper on NCT06265415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06265415.